JB Chemicals & Pharmaceuticals Limited

JB Chemicals & Pharmaceuticals Ltd (JBCPL) is a leading Indian pharmaceutical company engaged in the development, manufacture, and marketing of a broad portfolio spanning formulations, active pharmaceutical ingredients (APIs), and specialty products. Established in 1976 and headquartered in Mumbai, the company has built a strong presence in both domestic and international markets, exporting to over 40 countries. Its key therapy areas include gastrointestinal, cardiovascular, anti-infectives, and pain management, with flagship brands such as Rantac and Metrogyl driving significant revenues.

JBCPL operates state-of-the-art manufacturing facilities approved by major regulatory authorities, including the US FDA, MHRA (UK), TGA (Australia), and SAHPRA (South Africa). The company leverages continual investments in R&D and compliance to strengthen its pipeline, focusing on branded generics, specialty, and contract manufacturing partnerships.